Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET)

European Journal of Clinical Nutrition

Volumn 59, Issue 10, 2005, Pages 1173-1180

  Cartmel, Brenda ^a   Dziura, J ^b   Cullen, M R ^a,b   Vegso, S ^c   Omenn, G S ^c   Goodman, G E ^d   Redlich, C A ^a,b  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d SWEDISH MEDICAL CENTER   (United States)

Author keywords

Beta carotene; Cholesterol; Randomized trial; Triglycerides; Vitamin A

Indexed keywords

ASBESTOS; BETA CAROTENE; CHOLESTEROL; PLACEBO; RETINOL; TRIACYLGLYCEROL;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG FATALITY; FEMALE; HUMAN; LIPID ANALYSIS; MALE; MORTALITY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIOXIDANTS; ASBESTOS; CARDIOVASCULAR DISEASES; CAROTENOIDS; CHOLESTEROL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; TRIGLYCERIDES; VITAMIN A;

EID: 27144537828     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602229     Document Type: Article

References (45)

1. Austin MA, Hokanso JE & Edwards KL (1998): Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol. 81, 7B-12B.
2. Bershad S, Rubinstein A, Paterniti JR, Le NA, Poliak SC, Heller B, Ginsberg HN, Fleishmajer R & Brown WV (1985): Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N. Engl. J. Med. 313, 981-985.
3. Betteridge DJ & Morrell JM (1998): Clinicians' Guide to Lipids and Coronary Heart Disease. London: Chapman and Hall Medical.
4. Bowen D, Cartmel B, Barnett M, Goodman GE & Omenn GS (1999): Predictors of participant retention in two chemoprevention feasibility trials. Ann. Behav. Med. 21, 210-215.
5. Brown H & Prescott R (1999): Applied Mixed Models in Medicine. Chichester, England: John Wiley and Sons.
6. Cartmel B, Moon TE & Levine N (1999): The effects of long term intake of retinol on selected clinical and laboratory parameters. Am. J. Clin. Nutr. 69, 937-943.
7. Cooper GR, Myers GL, Smith SJ & Schlant RC (1992): Blood lipid measurements. Variations and practical utility. JAMA 267, 1652-1660.
8. Ferrara A, Barrett-Connor E & Shan J (1997): Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation 96, 37-43.
9. Frank E, Winkleby MA, Fortmann SP, Rockhill B & Farquhar JW (1992): Improved cholesterol-related knowledge and behavior and plasma cholesterol levels in adults during the 1980s. JAMA 268, 1566-1572.
10. Goodman GE, Omenn GS, Thornquist MD, Lund B, Metch B & Gylys-Colwell I (1993): The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: Pilot study with cigarette smokers. Cancer Epidemiol. Biomarkers Prev. 2, 389-396.
11. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons F, Marks GC, Gaffney F, Battistutta D, Frost C, Lang C & Russell A (1999): Daily sunscreen application and beta-carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin; a randomized controlled trial. Lancet 354, 723-729.
12. Greenberg ER, Baron JA, Karagas MR, Stukel TA, Nierenberg DW, Stevens MM, Mandel JS & Haile RW (1996): Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 275, 699-703.
13. Grundy SM (1986): Cholesterol and coronary heart disease. A new era. JAMA 256, 2849-2858.
14. Heart Protection Study Collaborative Group (2002): MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: A randomized placebo-controlled trial. Lancet 360, 23-33.
15. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W & Peto R (1996): Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. New. Engl. J. Med. 334, 1145-1149.
16. Hughes Jr GS, Ringer TV, Francom SF, Means LK & DeLoof MJ (1994): Lack of effects of beta-carotene on lipids and sex steroid hormones in hyperlipidemics. Am. J. Med. Sci. 308, 16-22.
17. Infante M, Pastorino U, Chiesa G, Bera E, Pisani F, Valente M & Raviasi G (1991): Laboratory evaluation during high-dose vitamin A administration: A randomized study of lung cancer patients after surgical resection. J. Cancer Res. Clin. Oncol. 117, 156-162.
18. Law MR, Wald NJ & Thompson SG (1994a): By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 308, 367-373.
19. Law MR, Wald NJ, Wu T, Hackshaw A & Bailey A (1994b): Systematic underestimation of association between serum cholesterol concentrations and ischaemic heart disease in observation studies: Data from the BUPA study. BMJ 308, 363-366.
20. Lee I, Cook NR, Manson JE, Buring JE & Hennekens CH (1999): Beta-carotene supplementation and incidence of cancer and cardiovascular disease: The Women's Health Study. J. Natl. Cancer Inst. 91, 2102-2106.
21. Manolio TA, Cushman M, Gottdiener JS, Dobs A, Kuller LH & Kronmal RA (2004): Predictors of falling cholesterol levels in older adults: The Cardiovascular Health Study. Ann. Epidemiol. 14, 325-331.
22. Marsden J (1986): Hyperlipidaemia due to isotretinoin and etretinate: possible mechanisms and consequences. Br. J. Dermatol. 114, 401-407.
23. Murray JC, Gilor RS & Lazarus GS (1983): Serum triglyceride elevation following high-dose vitamin A treatment for pityriasis rubra pilaris. Arch. Dermatol. 119, 675-676.
24. Newschaffer C, Bush TL & Hale WE (1992): Aging and total cholesterol levels: Cohort, period and survivorship effects. Am. J. Epidemiol. 136, 23-34.
25. Nierenberg DW, Bayrd GT & Stukel TA (1991): Lack of effect of chronic administration of oral beta-carotene on serum cholesterol and triglyceride concentrations. Am. J. Clin. Nutr. 53, 652-654.
26. Omenn GS, Goodman G, Thornquist M, Rosenstock LS, Barnhart S, Gylys-Colwell I, Metch B & Lund B (1993): The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high risk populations: pilot study with asbestos-exposed workers. Cancer Epidemiol. Biomarkers Prev. 2, 381-387.
27. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S & Hammar S (1996): Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334, 1150-1155.
28. Omenn GS, Goodman GE, Thornquist M & Brunzell JD (1994a): Long term vitamin A does not produce clinically significant hypertriglyceridemia: results from CARET, the Beta-Carotene and Retinol Efficacy Trial. Cancer Epidemiol. Biomarkers Prev. 3, 711-713.
29. Omenn GS, Goodman GE, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, Balmes J, Cherniack MG, Cullen MR & Glass A (1994b): The β-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high-risk populations: Smokers and asbestos-exposed workers. Cancer Res. 54, 2038-2043.
30. Pastorino U, Chiesa G, Infante M, Soresi E, Clerici M, Valente M, Bellon PA & Ravasi G (1991): Safety of high-dose vitamin A. Oncology 48, 131-137.
31. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR & Heinonene OP (1997): Randomized trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349, 1715-1720.
32. Redlich CA, Chung JS, Cullen MR, Blaner WS, Van Bennekum AM & Berglund L (1999): Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET). Atherosclerosis 143, 427-434.
33. Ribaya-Mercado JD, Ordovas JM & Russell RM (1995): Effect of beta-carotene supplementation of the concentrations and distribution of carotenoids, vitamin E, vitamin A and cholesterol in plasma lipoprotein and non-lipoprotein fractions in healthy older women. J. Am. Coll. Nutr. 14, 614-620.
34. Ringer TV, DeLoof MJ, Winterrowd GE, Francom SF, Gaylor SK, Ryan JA, Sanders ME & Hughes GS (1991): Beta-carotene's effects on serum lipoproteins and immunologic indices in humans. Am. J. Clin. Nutr. 53, 688-694.
35. Tangrea JA, Adrianza ME, Helxel WE, Taylor PR, Hartman AM, Peck GL & Edwards BK (1993): Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: Incidence and risk factors. Cancer Epidemiol. Biomarkers Prev. 2, 375-380.
36. The Alpha-Tocopherol, Beta-Carotene Prevention Study Group (1994): The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancer in male smokers. New Engl. J. Med. 330, 1029-1035.
37. Thornquist MD, Omenn GS, Goodman GE, Grizzle JE, Rosenstock L, Barnhart S, Anderson GL, Hammar S, Balmes J, Cherniack M, Cone J, Cullen MR, Glass A, Keogh JF, Meyskens F, Valanis B & Williams JH (1993): Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). Cont. Clin. Trials 14, 308-324.
38. Vahlquist C, Michaëlsson G, Vahlquist A & Vessby B (1985): A sequential comparison of etretinate (Tigason®) with special regard to their effects on serum lipoproteins. Br. J. Dermatol. 112, 69-76.
39. Van Poppel G, Hospers H, Buytenhek R & Princen HM (1994): No effects of beta-carotene supplementation on plasma lipoproteins in healthy smokers. Am. J. Clin. Nutr. 60, 730-734.
40. Virtamo J, Rapola JM, Ripatti S, Heinonen OP, Taylor PR, Albanes D & Huttunen JK (1998): Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Archives Int. Med. 158, 668-675.
41. Vivekananthan DP, Penn MS, Sapp SK, Hsu A & Topol EJ (2003): Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet 361, 2017-2023.
42. Wallace RB & Colsher PL (1992): Blood lipid distributions in older persons: Prevalence and correlates of hyperlipidemia. Ann. Epidemiol. 2, 15-21.
43. Weijenberg MP, Feskens EJ & Kromhout D (1996): Age-related changes in total and high-density -lipoprotein cholesterol in elderly Dutch men. Am. J. Public Health. 86, 798-803.
44. Witztum JL (1994): The oxidation hypothesis of atherosclerosis. Lancet 344, 793-795.
45. Zech LA, Gross EF, Peck GL & Brewer HB (1983): Changes in plasma cholesterol and triglyceride levels after treatment with oral isotretinoin. A prospective study. Arch. Dermatol. 119, 987-993.